Application

16251143 · NOVEL ANTITUMORAL USE OF CABAZITAXEL

Filed 2019-01-18 · Abandoned The official file ↗ · Art unit 1629 · Examiner James D Anderson Typical · CPC A61K 31/337 · Aventis Pharma S.A. · LISA P. RASMUSSEN

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

1.3 mo

to disposition 13.2 mo

Statutes raised

102 103 112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.